ABL
Dominique Dumirier has a strong background in Quality Assurance and Production Management within the pharmaceutical and food industry. They have experience in managing production campaigns, improving industrial performance, leading teams, and ensuring compliance with quality and safety standards. With a Bachelor's degree in QSAPBS and a BTS in Biochemistry, Dominique has a solid foundation in quality control and biochemistry. They have worked in various companies such as ABL Europe, Colin Palc, Eli Lilly and Company, Roquette, and Mars Petcare, gaining expertise in quality assurance, documentation management, audit, and project management.
ABL
From development to market ABL Europe provides GMP viral vectors, contributing to the success of our clients’ immunotherapy innovations. ABL Europe SAS is a pure-play GMP CMO licensed in accordance with EMA, completely dedicated to the provision of viral vector GMP contract manufacturing services, and a subsidiary of ABL Inc. under the corporate ownership of Institut Mérieux. ABL has a strong technical & regulatory track record in process development, scale-up & GMP manufacturing of filterable & non-sterile filterable (aseptic processing) viral vectors used in all phases of clinical development globally. With different adherent platforms (< 60 m2) and suspension (< 500 L) capabilities for drug substance and drug product (< 10,000 vials per batch) in-house, experience in process characterisation and validation, ABL provides its clients with a long-term strategic manufacturing option through clinical development & licensure for a range of virus vector gene therapy & vaccine products. ABL Europe’s clients are located worldwide.